Discover ASX Penny Stocks To Watch In December 2024

In This Article:

The ASX200 has experienced a modest rise, with the IT sector leading gains and Health Care lagging behind. In this context, penny stocks—though an older term—still represent an intriguing investment area for those seeking opportunities in smaller or emerging companies. By focusing on firms with solid financials and growth potential, investors can uncover promising prospects among these lesser-known stocks.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

Embark Early Education (ASX:EVO)

A$0.80

A$146.79M

★★★★☆☆

LaserBond (ASX:LBL)

A$0.55

A$64.47M

★★★★★★

Helloworld Travel (ASX:HLO)

A$2.05

A$333.78M

★★★★★★

Austin Engineering (ASX:ANG)

A$0.54

A$334.88M

★★★★★☆

MaxiPARTS (ASX:MXI)

A$1.83

A$101.23M

★★★★★★

SHAPE Australia (ASX:SHA)

A$2.79

A$231.32M

★★★★★★

Navigator Global Investments (ASX:NGI)

A$1.69

A$828.23M

★★★★★☆

Vita Life Sciences (ASX:VLS)

A$2.01

A$113.04M

★★★★★★

Big River Industries (ASX:BRI)

A$1.30

A$110.99M

★★★★★☆

Servcorp (ASX:SRV)

A$4.86

A$479.51M

★★★★☆☆

Click here to see the full list of 1,044 stocks from our ASX Penny Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Cogstate

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Cogstate Limited is a neuroscience technology company focused on developing and commercializing digital brain health assessments for academic and industry-sponsored research, with a market cap of A$172.34 million.

Operations: The company's revenue is derived from two main segments: Healthcare (including Sport) generating $3.99 million and Clinical Trials (including Precision Recruitment Tool & Research) contributing $39.44 million.

Market Cap: A$172.34M

Cogstate Limited, with a market cap of A$172.34 million, has shown strong financial health and growth potential within the penny stock category. The company’s revenue is primarily driven by its Clinical Trials segment, contributing A$39.44 million, and it has demonstrated significant earnings growth of 52.8% over the past year. Cogstate's recent partnership with Medidata aims to enhance clinical trial efficiency for CNS diseases, potentially boosting its market position. Additionally, a share repurchase program reflects confidence in its valuation while maintaining stable debt levels covered by cash flow and short-term assets exceeding liabilities.

ASX:CGS Financial Position Analysis as at Dec 2024
ASX:CGS Financial Position Analysis as at Dec 2024

Otto Energy

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Otto Energy Limited is an oil and gas exploration, production, and sales company operating in North America with a market capitalization of A$57.54 million.